Index RUT P/E - EPS (ttm) -1.34 Insider Own 35.57% Shs Outstand 30.62M Perf Week -4.09%
Market Cap 599.74M Forward P/E - EPS next Y -0.63 Insider Trans 0.87% Shs Float 19.62M Perf Month 11.55%
Income -40.78M PEG - EPS next Q -0.18 Inst Own 51.57% Short Float 8.98% Perf Quarter 22.06%
Sales 292.45M P/S 2.05 EPS this Y -212.57% Inst Trans 0.83% Short Ratio 3.60 Perf Half Y -10.58%
Book/sh 36.81 P/B 0.54 EPS next Y -13.73% ROA -3.35% Short Interest 1.76M Perf Year -7.60%
Cash/sh 10.52 P/C 1.87 EPS next 5Y - ROE -3.61% 52W Range 14.57 - 25.11 Perf YTD 6.66%
Dividend Est. - P/FCF - EPS past 5Y -129.89% ROI -3.60% 52W High -21.55% Beta 1.01
Dividend TTM - Quick Ratio 6.32 Sales past 5Y 247.79% Gross Margin 36.07% 52W Low 35.21% ATR (14) 0.93
Dividend Ex-Date - Current Ratio 6.32 EPS Y/Y TTM 76.00% Oper. Margin -24.59% RSI (14) 58.67 Volatility 6.92% 4.72%
Employees 1313 Debt/Eq 0.01 Sales Y/Y TTM 1.71% Profit Margin -13.94% Recom 2.67 Target Price 22.67
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 17.29% Payout - Rel Volume 0.75 Prev Close 18.56
Sales Surprise 3.09% EPS Surprise 122.30% Sales Q/Q 13.92% Earnings May 02 BMO Avg Volume 490.09K Price 19.70
SMA20 5.49% SMA50 11.44% SMA200 1.60% Trades
Volume 368,996 Change 6.14%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Initiated UBS
Neutral
$35
Dec-08-22 Downgrade Piper Sandler
Overweight → Neutral
$65 → $40
Nov-18-22 Initiated Raymond James
Outperform
$45
Aug-25-22 Initiated Credit Suisse
Outperform
$65
Feb-04-22 Resumed Piper Sandler
Overweight
$80
Aug-05-21 Resumed Credit Suisse
Underperform
$55
Jan-08-21 Downgrade Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade BTIG Research
Buy → Neutral
Aug-20-20 Initiated Oppenheimer
Outperform
$75
May-29-20 Initiated BTIG Research
Buy
$20
Nov-05-19 Upgrade Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade Raymond James
Outperform → Mkt Perform
Show Previous Ratings
May-03-25 03:03AM
May-02-25 11:35PM
(Thomson Reuters StreetEvents) +19.07%
12:27PM
08:10AM
07:00AM
04:37PM
Loading…
Apr-21-25 04:37PM
Apr-10-25 04:05PM
Apr-04-25 02:30PM
Mar-24-25 08:01AM
Mar-20-25 05:46AM
Mar-07-25 06:19PM
Feb-28-25 11:30PM
(Thomson Reuters StreetEvents)
08:10AM
07:00AM
Feb-06-25 04:05PM
09:55AM
Loading…
Dec-09-24 09:55AM
Nov-22-24 12:00PM
Nov-19-24 07:16PM
Nov-09-24 07:31AM
02:05AM
Nov-08-24 08:15AM
07:00AM
Nov-05-24 08:00AM
Nov-01-24 08:08AM
Oct-31-24 08:00AM
Oct-17-24 04:05PM
Aug-13-24 12:00PM
09:55AM
Aug-02-24 08:15AM
07:00AM
04:36AM
Loading…
Jul-18-24 04:36AM
Jul-11-24 04:05PM
Jun-10-24 01:00AM
Jun-03-24 08:00AM
May-24-24 08:00AM
May-15-24 04:21AM
(Pharmaceutical Technology)
May-14-24 04:05PM
09:00AM
May-04-24 09:15AM
03:04AM
May-03-24 10:46PM
(Thomson Reuters StreetEvents)
11:53AM
08:34AM
08:15AM
07:00AM
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
(Thomson Reuters StreetEvents) -8.14%
07:35AM
07:00AM
Feb-13-24 08:00AM
Feb-09-24 08:31AM
Nov-25-23 09:45AM
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
(Thomson Reuters StreetEvents) +13.24%
04:05PM
08:52AM
08:45AM
07:00AM
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
(Thomson Reuters StreetEvents)
-12.82%
08:15AM
07:00AM
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
(Thomson Reuters StreetEvents)
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kim Paul CFO and Treasurer Mar 05 '25 Buy 15.96 100,000 1,596,470 348,282 Mar 05 06:47 PM Xie Jian President and COO Dec 03 '24 Sale 19.50 1,455 28,372 334,681 Dec 04 04:41 PM Gao Hanlin Chief Scientific Officer Dec 03 '24 Sale 19.50 1,373 26,773 919,469 Dec 04 04:40 PM Gao Hanlin Officer Dec 02 '24 Proposed Sale 19.25 1,397 26,892 Dec 02 07:10 PM Xie Jian Officer Dec 02 '24 Proposed Sale 19.25 1,483 28,548 Dec 02 07:10 PM Hsieh Ming Chief Executive Officer Nov 25 '24 Sale 18.26 2,227 40,663 703,711 Nov 27 05:00 PM Gao Hanlin Chief Scientific Officer Nov 25 '24 Sale 18.26 497 9,075 920,842 Nov 27 05:00 PM Xie Jian President and COO Nov 25 '24 Sale 18.26 689 12,581 336,136 Nov 27 05:00 PM Xie Jian Officer Nov 25 '24 Proposed Sale 18.26 689 12,581 Nov 25 07:04 PM Gao Hanlin Officer Nov 25 '24 Proposed Sale 18.26 497 9,075 Nov 25 07:03 PM Hsieh Ming Owner Nov 25 '24 Proposed Sale 18.26 2,227 40,663 Nov 25 07:03 PM Kim Paul CFO and Treasurer Sep 03 '24 Sale 21.96 1,674 36,763 209,481 Sep 05 04:21 PM Xie Jian President and COO Sep 03 '24 Sale 21.96 1,594 35,006 341,170 Sep 05 04:21 PM Gao Hanlin Chief Scientific Officer Sep 03 '24 Sale 21.96 1,503 33,007 923,057 Sep 05 04:20 PM Xie Jian Officer Sep 03 '24 Proposed Sale 21.96 1,594 35,006 Sep 03 07:37 PM Kim Paul Officer Sep 03 '24 Proposed Sale 21.96 1,674 36,763 Sep 03 07:36 PM Gao Hanlin Chief Scientific Officer Aug 27 '24 Sale 22.83 563 12,855 924,560 Aug 29 06:34 PM Xie Jian President and COO Aug 27 '24 Sale 22.83 715 16,326 342,764 Aug 29 06:33 PM Hsieh Ming Chief Executive Officer Aug 27 '24 Sale 22.83 2,313 52,813 707,275 Aug 29 06:33 PM Kim Paul CFO and Treasurer Aug 27 '24 Sale 22.83 733 16,737 211,155 Aug 29 06:33 PM Hsieh Ming Owner Aug 27 '24 Proposed Sale 22.83 2,313 52,813 Aug 27 08:22 PM
